Gastric cancer

• A Study to Determine the Effectiveness of a Test Drug ([68Ga]BED003) for the Detection of Pancreatic, Colorectal, Gastric, Breast and Ovaria … Pending
  2025-521983-36-00 4 "Colorectal cancer (CRC), gastric cancer (GC), pancreatic duc"
• Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors Pending
  2025-523232-39-00 1 "Advanced Solid Tumors"
• A Phase 1/2, Multicenter, Open-label, Dose Escalation and Dose Expansion Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, a … Pending
  2025-523590-42-00 7 "Locally Advanced or Metastatic Solid Tumors"
• A Study of Disitamab Vedotin with Other Anticancer Drugs in Solid Tumors Recruiting
  2023-507555-29-00 9 2024-08-16 "LA/mGC/GEJC (locally advanced unresectable or metastatic gas"
• A Phase 1 Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of BGB-B2033, … Recruiting
  2025-524136-19-00 1 2026-04-28 "Selected Advanced or Metastatic Solid Tumors"
• Study of Pumitamig in Combination with Chemotherapy Versus Nivolumab in Combination with Chemotherapy in Previously Untreated Advanced or Me … Recruiting
  2025-523263-37-00 10 2026-04-08 "Previously Untreated Advanced or Metastatic Gastric, Gastroe"
• A Phase 2 study of zanidatamab in patients with HER2-expressing tumors Recruiting
  2024-516551-41-00 4 2026-03-06 "Patients with HER2-expressing solid tumors"
• Study aiming to compare the survival of patients with locally advanced or metastatic MSI/dMMR Esogastric adenocarcinomas treated by a combin … Recruiting
  2023-506291-28-00 5 2026-03-02 "Patient with locally advanced/metastatic, MSI-H/dMMR gastric"
• A Phase 1a/1b, Open-Label Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity … Recruiting
  2025-523165-19-00 1 2026-02-10 "Advanced, metastatic or unresectable solid tumors"
• The purpose of this study is to determine whether Tislelizumab, when given as a subcutaneous (SC) injection, reaches the same drug levels in … Recruiting
  2025-522862-58-00 5 2026-01-09 "Locally advanced unresectable or metastatic gastric or gastr"
• A First-in-human Study to Evaluate the Safety and Anticancer Effect of Several Doses of TH9619 in Patients with Advanced Cancer (ODIN). Recruiting
  2024-519639-40-00 1 2025-08-18 "Solid tumors (including Non-Small Cell Lung Cancer (NSCLC), "
• A Randomized, Double-blinded, Multicenter, Phase Ⅲ Clinical Study of HLX22 (Recombinant Humanized Anti-HER2 Monoclonal Antibody Injection) i … Recruiting
  2024-516633-12-00 5 2025-06-30 "Locally advanced/ metastatic gastroesophageal junction and g"
• First -in-Human Study of DS-3939a in Subjects with Advanced Solid Tumors Recruiting
  2023-507937-14-00 7 2025-03-25 "Metastatic Solid Tumor"
• A study to learn more about how well treatment with sevabertinib (BAY2927088) tablets works and how safe it is in participants who have a so … Recruiting
  2024-517419-62-00 4 2025-02-28 "HER2 mutation"
• A Phase 1a/1b Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of the CD … Recruiting
  2023-506888-34-00 1 2024-05-22 "Advanced or metastatic solid tumors including hormone recept"
• A Study of Sigvotatug Vedotin in Advanced Solid Tumors Recruiting
  2023-508469-34-00 1 2020-10-14 "Esophageal cancer"
• A clinical study of the safety and effectiveness of an investigational cell therapy given with and without an investigational RNA-based vacc … Recruiting
  2024-514962-38-00 1 2020-08-25 "Solid Tumors"
• A Study of Zolbetuximab Together with Pembrolizumab and Chemotherapy in Adults with Gastric Cancer Recruitment ended
  2024-519773-19-00 5 2025-07-31 "Gastroesophageal Junction Adenocarcinoma"
• A study to evaluate the safety and the activity of S095029 as a part of combination therapy in advanced gastroesophageal junction/gastric ca … Recruitment ended
  2023-507995-33-00 9 2024-05-23 "MSI-H/dMMR Gastric cancer"
• This is a Global Study of Neoadjuvant-Adjuvant Durvalumab or Placebo and FLOT Chemotherapy Followed by Adjuvant Durvalumab or Placebo in Pat … Recruitment ended
  2023-507338-26-00 5 2021-02-01 "Histologically documented gastric or gastroesophageal juncti"
• This study will evaluate the safety, tolerability, and pharmacokinetics of Runimotamab administered intravenously as a single agent and in c … Recruitment ended
  2023-504491-15-00 1 2020-10-30 "Human epidermal growth factor receptor (HER2)-Expressing Can"
• A Phase 1b Dose Escalation Study of Cabozantinib (XL184) Administered Alone or in Combination with Atezolizumab to Subjects with Locally Adv … Recruitment ended
  2024-516477-73-00 3 2018-03-07 "Bladder cancer and kidney cancer"
• A study of PF-08046050 (SGN-CEACAM5C) in adults with advanced solid tumors Halted
  2023-505858-18-00 1 2024-06-28 "Pancreatic carcinoma"
• 68Ga-FAPI PET/CT: The Diagnostic Accuracy for Primary Staging and Re-staging after Chemotherapy in Patients with Gastric and Gastro-Esophage … Ended
  2023-505916-40-01 4 2024-02-15 "Gastroesophageal junction cancer (GEJ-cancer)"

Showing 1–24 of 36 trials